Peter Spégel
51 – 60 of 96
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist.
(
- Contribution to journal › Article
-
Mark
Metabolite profile deviations in an oral glucose tolerance test-A comparison between lean and obese individuals.
(
- Contribution to journal › Article
-
Mark
Chronic high glucose and pyruvate levels differentially affect mitochondrial bioenergetics and fuel-stimulated insulin secretion from clonal INS-1 832/13 cells.
(
- Contribution to journal › Article
-
Mark
Loss of TFB1M results in mitochondrial dysfunction that leads to impaired insulin secretion and diabetes.
(
- Contribution to journal › Article
-
Mark
Glucose-dependent insulinotropic polypeptide lowers branched chain amino acids in hyperglycemic rats.
(
- Contribution to journal › Article
-
Mark
Gastric bypass improves ss-cell function and increases β-cell mass in a porcine model.
(
- Contribution to journal › Article
- 2013
-
Mark
The transcriptional co-repressor myeloid translocation gene 16 inhibits glycolysis and stimulates mitochondrial respiration.
(
- Contribution to journal › Article
-
Mark
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice.
(
- Contribution to journal › Article
-
Mark
Time-resolved metabolomics analysis of beta-cells implicates the pentose phosphate pathway in the control of insulin release
(
- Contribution to journal › Article
-
Mark
Coordinate changes in histone modifications, mRNA levels and metabolite profiles in clonal INS-1 832/13 β-cells accompany functional adaptations to lipotoxicity.
(
- Contribution to journal › Article